Literature DB >> 28176357

BRI2 Processing and Its Neuritogenic Role Are Modulated by Protein Phosphatase 1 Complexing.

Filipa Martins1, Joana B Serrano1, Thorsten Müller2, Odete A B da Cruz E Silva1, Sandra Rebelo1.   

Abstract

BRI2 is a ubiquitously expressed type II transmembrane phosphoprotein. BRI2 undergoes proteolytic processing into secreted fragments and during the maturation process it suffers post-translational modifications. Of particular relevance, BRI2 is a protein phosphatase 1 (PP1) interacting protein, where PP1 is able to dephosphorylate the former. Further, disruption of the BRI2:PP1 complex, using BRI2 PP1 binding motif mutants, leads to increased BRI2 phosphorylation levels. However, the physiological function of BRI2 remains elusive; although findings suggest a role in neurite outgrowth and neuronal differentiation. In the work here presented, BRI2 expression during neuronal development was investigated. This increases during neuronal differentiation and an increase in its proteolytic processing is also evident. To elucidate the importance of BRI2 phosphorylation for both proteolytic processing and neuritogenesis, SH-SY5Y cells were transfected with the BRI2 PP1 binding motif mutant constructs. For the first time, it was possible to show that BRI2 phosphorylation is an important regulatory mechanism for its proteolytic processing and its neuritogenic role. Furthermore, by modulating BRI2 processing using an ADAM10 inhibitor, a dual role for BRI2 in neurite outgrowth is suggested: phosphorylated full-length BRI2 appears to be important for the formation of neuritic processes, and BRI2 NTF promotes neurite elongation. This work significantly contributed to the understanding of the physiological function of BRI2 and its regulation by protein phosphorylation. J. Cell. Biochem. 118: 2752-2763, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADAM10; BRI2; NEURITOGENESIS; PROTEIN COMPLEXES; PROTEIN PHOSPHORYLATION; PROTEOLYTIC PROCESSING

Mesh:

Substances:

Year:  2017        PMID: 28176357     DOI: 10.1002/jcb.25925

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.

Authors:  Tobias Brummer; Stephan A Müller; Francisco Pan-Montojo; Fumiaki Yoshida; Andreas Fellgiebel; Taisuke Tomita; Kristina Endres; Stefan F Lichtenthaler
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

2.  In Vitro Cytotoxicity Effects of Zinc Oxide Nanoparticles on Spermatogonia Cells.

Authors:  Ana Rita Pinho; Filipa Martins; M Elisabete V Costa; Ana M R Senos; Odete A B da Cruz E Silva; Maria de Lourdes Pereira; Sandra Rebelo
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

3.  Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study.

Authors:  Tiago Mateus; Idália Almeida; Adriana Costa; Diana Viegas; Sandra Magalhães; Filipa Martins; Maria Teresa Herdeiro; Odete A B da Cruz E Silva; Carla Fraga; Ivânia Alves; Alexandra Nunes; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

4.  Identification and characterization of the BRI2 interactome in the brain.

Authors:  Filipa Martins; Ana M Marafona; Cátia D Pereira; Thorsten Müller; Christina Loosse; Katharina Kolbe; Odete A B da Cruz E Silva; Sandra Rebelo
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

5.  Nuclear Accumulation of LAP1:TRF2 Complex during DNA Damage Response Uncovers a Novel Role for LAP1.

Authors:  Cátia D Pereira; Filipa Martins; Mariana Santos; Thorsten Müeller; Odete A B da Cruz E Silva; Sandra Rebelo
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

Review 6.  Secreted Chaperones in Neurodegeneration.

Authors:  Kriti Chaplot; Timothy S Jarvela; Iris Lindberg
Journal:  Front Aging Neurosci       Date:  2020-08-27       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.